Stanford Health Care’s Janjri Desai, Pharm.D., says pharmacists improve outcomes but often can’t bill for it, making billing parity key to growing services.
|Articles|February 1, 2003
OTCs stem pharm costs, but the jury's still out on long-term savings
The launch of OTC antihistamines helps plans cut costs, but skeptics argue that accessibility will suffer because of cost barriers
Advertisement
Advertisement
Related to this article
Stanford Health Care’s Janjri Desai, Pharm.D., says pharmacy should be treated as a clinical service line, not just a 340B financial workhorse.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Medicaid can't opt out of gene therapies, so planning matters more, says Katelyn Meyer, Pharm.D. | AMCP Nexus 2026
2
Lower fitness tied to persistent fatty liver disease in teen boys with obesity
3
Updated HIV treatment guidelines address payer barriers and add Bixlenvo
4
How common is atopic dermatitis in the US? Not nearly as common as other research has shown, according to this study
5